A global risk approach to identify patients with left main or 3-vessel disease who could safely and efficaciously be treated with percutaneous coronary intervention: The SYNTAX trial at 3 years

Patrick W. Serruys, Vasim Farooq, Pascal Vranckx, Chrysafios Girasis, Salvatore Brugaletta, Hector M. Garcia-Garcia, David R. Holmes, Arie Pieter Kappetein, Michael J. Mack, Ted Feldman, Marie Claude Morice, Elisabeth Ståhle, Stefan James, Antonio Colombo, Peggy Pereda, Jian Huang, Marie Angèle Morel, Gerrit Anne Van Es, Keith D. Dawkins, Friedrich W. MohrEwout W. Steyerberg

Research output: Contribution to journal › Article › peer-review

80 Scopus citations

Fingerprint

Dive into the research topics of 'A global risk approach to identify patients with left main or 3-vessel disease who could safely and efficaciously be treated with percutaneous coronary intervention: The SYNTAX trial at 3 years'. Together they form a unique fingerprint.

Medicine & Life Sciences